Tomohiro Matsushima
Tomohiro Matsushima publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Surgery, on topics such as Gastric Cancer Management and Outcomes, Colorectal Cancer Treatments and Studies and Metastasis and carcinoma case studies.
- World rank
- #6,902,613 of 7,710,434 ranked researchers
- Rank in Japan
- #297,931 of 383,136
- Works
- 89
- Citations
- 501
- Citations per work
- 5.6
What does Tomohiro Matsushima research?
Tomohiro Matsushima's work is mostly in Medicine (78%), Biochemistry, Genetics and Molecular Biology (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences7078.4%
- Medicine7078.4%
- Everything else1718.9%
- Life Sciences22.7%
- 1Pulmonary and Respiratory Medicine36% of their works
- 2Oncology22% of their works
- 3Surgery14% of their works
- 4Gastroenterology4% of their works
- 5Epidemiology3% of their works
- 6Cancer Research3% of their works
Research topics
- Gastric Cancer Management and Outcomes
- Colorectal Cancer Treatments and Studies
- Metastasis and carcinoma case studies
- Cholangiocarcinoma and Gallbladder Cancer Studies
- HER2/EGFR in Cancer Research
- Gastrointestinal Tumor Research and Treatment
- Lung Cancer Treatments and Mutations
- Helicobacter pylori-related gastroenterology studies
Which keywords describe Tomohiro Matsushima's research?
The keywords of their largest research topics: Chemotherapy, Gastric Cancer, Endoscopic Resection, Molecular Characterization, Cetuximab, KRAS Mutations, Breast Cancer and Prognostic Factors.
- Helicobacter pylori
- Sunitinib
- EGFR Mutations
- HER2
- Biliary Tract Cancer
- Lung Tumors
- Prognostic Factors
- KRAS Mutations
- Molecular Characterization
- Gastric Cancer
- Chemotherapy
- Endoscopic Resection
- Cetuximab
- Breast Cancer
- Surgical Management
- Metastatic Carcinomas
- Cholangiocarcinoma
- Trastuzumab
- Imatinib Mesylate
- Targeted Therapy
- Inflammation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Chemotherapy793 topics
- Gastric Cancer532 topics
- Endoscopic Resection461 topic
- Molecular Characterization461 topic
- Cetuximab241 topic
- KRAS Mutations241 topic
- Breast Cancer212 topics
- Prognostic Factors182 topics
- Surgical Management182 topics
- Lung Tumors121 topic
- Metastatic Carcinomas121 topic
- Biliary Tract Cancer101 topic
- Cholangiocarcinoma101 topic
- HER291 topic
- Trastuzumab91 topic
- EGFR Mutations81 topic
- Imatinib Mesylate81 topic
- Sunitinib81 topic
- Targeted Therapy81 topic
- Helicobacter pylori71 topic
- Inflammation71 topic
Where does Tomohiro Matsushima work?
Tomohiro Matsushima's main affiliation in the publication record is Japanese Foundation For Cancer Research, Japan.
How many publications and citations does Tomohiro Matsushima have?
OpenAlex counts 89 works and 501 citations for Tomohiro Matsushima, an h-index of 11, ranking #6,902,613 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Tomohiro Matsushima
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Tomohiro Matsushima. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.